Page last updated: 2024-08-23

pirfenidone and Hepatic Veno Occlusive Disease

pirfenidone has been researched along with Hepatic Veno Occlusive Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Han, J; Liu, X; Ma, X; Wang, X; Xu, J; Yuan, J; Zhao, L	1

Other Studies

1 other study(ies) available for pirfenidone and Hepatic Veno Occlusive Disease

Article	Year
Busulfan-induced hepatic sinusoidal endothelial cell injury: Modulatory role of pirfenidone for therapeutic purposes. Toxicology in vitro : an international journal published in association with BIBRA, 2023, Volume: 92 Topics: Busulfan; Chemical and Drug Induced Liver Injury; Endothelial Cells; Hepatic Veno-Occlusive Disease; Humans; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1	2023

Article

Year

Busulfan-induced hepatic sinusoidal endothelial cell injury: Modulatory role of pirfenidone for therapeutic purposes.

Toxicology in vitro : an international journal published in association with BIBRA, 2023, Volume: 92

Topics: Busulfan; Chemical and Drug Induced Liver Injury; Endothelial Cells; Hepatic Veno-Occlusive Disease; Humans; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1

2023